Pathogenic somatic alterations of DDR genes in lung cancer are significantly different from germline mutations and are associated with more unstable genomes
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
To the Editor
The defects DNA-damage repair (DDR) genes would drive tumor formation and are associated with increased genomic instability and tumor mutational burden (TMB) in cancer [1]. Although, alterations of DDR genes are common in NSCLC, the differences between the germline and somatic alterations are poorly characterized.
Anzeige
The DNA sequencing data of 540 genes from 5235 lung cancer patients were retrospectively collected and 276 DDR genes were analyzed [2]. The variations were annotated as pathogenic (P), likely pathogenic (LP), and non-pathogenic (NP) according to ACMG (American College of Medical Genetics) guideline. The patients were divided into 3 groups (Table 1): DDR-germline (P&LP germline variants, N = 650), DDR-somatic group (only P&LP somatic variants, N = 1489) and the non-DDR group (NP variants, N = 3096). The DDR-somatic group had a higher median age and the highest proportion of males, stage IV and LUSC patients.
Table 1
Comparison of clinical data for NSCLC patients in non-DDR, DDR-somatic, and DDR-germline groups
Characteristics
N
Level
non_DDR N (%)
DDR_somatic N (%)
DDR_germline N (%)
P value
Total
5235
3096
1489
650
Age
5232
62 (16–94)
64 (23–107)
62 (27–92)
1.43E−07
Gender
5235
Female
1590 (51.36%)
554 (37.21%)
293 (45.08%)
1.9443E−18
Male
1506 (48.64%)
935 (62.79%)
357 (54.92%)
Stage
2380
I
255 (19.26%)
48 (6.43%)
48 (15.48%)
5.2446E−13
II
129 (9.74%)
59 (7.91%)
29 (9.35%)
III
242 (18.28%)
157 (21.05%)
64 (20.65%)
IV
698 (52.72%)
482 (64.61%)
169 (54.52%)
Dignosis
3888
NSCLC
2266 (98.65%)
1075 (96.85%)
475 (98.75%)
0.00071134
SCLC
31 (1.35%)
35 (3.15%)
6 (1.25%)
Subtype
3544
LUAD
1923 (91.22%)
827 (82.95%)
382 (87.02%)
1.0291E−09
LUSC
148 (7.02%)
140 (14.04%)
50 (11.39%)
Others
37 (1.76%)
30 (3.01%)
7 (1.59%)
The most commonly germline alterations were found in BRCA2 (8.46%), ERCC2 (8.15%) and IDH1 (8%), while in the somatic mutations, TP53 (89.05%) showed the highest frequency (Fig. 1A, B). Among the ten functional categories of DDR genes, the mutations of Fanconi anemia (FA) (234, 36.00%) and homology-dependent recombination (HR) (249, 38.31%) signaling were enriched in germline, while other categories (1417, 95.10%) were more common in somatic alterations.
Fig. 1
DDR gene mutation landscapes of the DDR-germline (A) and DDR-somatic (B) groups and the comparation of the alterations in actionable genes among the three groups (C)
×
In pairwise comparisons of the three groups, 28 actionable mutations were assessed based on OncoKB [3]. DDR-somatic group was more likely to have alterations in PTEN (OR = 0.46), FGFR1 (OR = 0.48), NTRK1 (OR = 0.46) compared with DDR-germline group. Taken non-DDR group as reference, mutations in ALK (OR = 1.94), CDK12 (OR = 2.62), STK11 (OR = 1.58) were more common in DDR-germline group, but CDKN2A (OR = 2.13), NF1 (OR = 2), NTRK3 (OR = 2.06) in DDR-somatic group (Fig. 1C).
The tumor mutational burden (TMB) was statistically different among the three groups (P < 2.22e−16). The DDR-somatic group exhibits the highest median TMB (12.39) compared with 7.44 in DDR-germline and 5.24 in non-DDR group. In addition, the proportion of MSI-H patients in DDR-somatic group is the highest (0.94%) compared with 0.62% in DDR-germline group and 0.23% in non-DDR group (P = 0.0040) (Fig. 2A).
Fig. 2
The differences of TMB in the DDR-germline, DDR-somatic and non-DDR groups (A) and the immune microenvironment assays in the DDR mutation and wild type groups (B)
×
Anzeige
The genetic data of 1053 lung cancer patients were downloaded from TCGA. The TCGA cohort was stratified into DDR-somatic and non-DDR groups according to the pathogenic annotation by Clinvar. Ten types of immune cells were found significantly associated with DDR status (Fig. 2B), Macrophages M0 (P = 0.0126), Macrophages M1 (P = 0.0002) and CD8 T cells (P = 0.0087) showed higher proportions in DDR-somatic group.
The differences in the mutation profile between the DDR-germline and DDR-somatic groups and the distinct actionable genes may indicate the different target-therapy choices for NSCLC patients. Besides, patients with somatic pathologic mutations exhibit the highest genome instability, including the highest TMB and the most MSI-H, and superior immune microenvironment consist of higher proportions of macrophages and CD8 cells infiltration. According to a previous report, patients with pathologic DDR mutations had higher objective response rate, longer median progression-free survival and overall survival with PD-L1 therapy [1]. This may indicate patients with somatic DDR alterations may better benefit from the immune checkpoint inhibition in NSCLC.
Acknowledgements
We thank Mr. Ran Ding, Mr. Guanghua Lu, and Mr. Wanglong Deng from Simcere Diagnostics for the kindly assistance.
Declarations
Ethics approval and consent to participate
This study used desensitized patient data for analysis and the ethics approval was waived.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Pathogenic somatic alterations of DDR genes in lung cancer are significantly different from germline mutations and are associated with more unstable genomes
verfasst von
Huaqing Wang Yue Zhao Fei Wang Xiaofeng Zhu Ningning Luo Tingting Sun Chuang Qi Xin Li
Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.
Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.
Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.
Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.
Update Innere Medizin
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.
